{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T20:09:37Z","timestamp":1777666177495,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.clim.2020.108391","type":"journal-article","created":{"date-parts":[[2020,3,27]],"date-time":"2020-03-27T11:16:39Z","timestamp":1585307799000},"page":"108391","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Prolonged intraocular residence and retinal tissue distribution of a fourth-generation compstatin-based C3 inhibitor in non-human primates"],"prefix":"10.1016","volume":"214","author":[{"given":"Sarah","family":"Hughes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin","family":"Gumas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merita","family":"Rumano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadja","family":"Berger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avneesh Kumar","family":"Gautam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgia","family":"Sfyroera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Lorena","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gopalan","family":"Gnanaguru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kip M.","family":"Connor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin J.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua L.","family":"Dunaief","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Ricklin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Hajishengallis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Despina","family":"Yancopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edimara S.","family":"Reis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios C.","family":"Mastellos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D.","family":"Lambris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2020.108391_bb0005","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.imbio.2015.11.007","article-title":"Age-related macular degeneration: complement in action","volume":"221","author":"van Lookeren","year":"2016","journal-title":"Immunobiology."},{"key":"10.1016\/j.clim.2020.108391_bb0010","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.molimm.2017.05.028","article-title":"The link between morphology and complement in ocular disease","volume":"89","author":"Mohlin","year":"2017","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.clim.2020.108391_bb0015","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1126\/science.1110359","article-title":"Complement factor H variant increases the risk of age-related macular degeneration","volume":"308","author":"Haines","year":"2005","journal-title":"Science (80-. )"},{"key":"10.1016\/j.clim.2020.108391_bb0020","doi-asserted-by":"crossref","first-page":"7227","DOI":"10.1073\/pnas.0501536102","article-title":"A common haplotype in the complement regulatory gene factor H (HF1\/CFH) predisposes individuals to age-related macular degeneration","volume":"102","author":"Hageman","year":"2005","journal-title":"Proc.Natl.Acad.Sci.U.S.A"},{"key":"10.1016\/j.clim.2020.108391_bb0025","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.molimm.2014.06.032","article-title":"Genetic variants in the complement system predisposing to age-related macular degeneration: a review","volume":"61","author":"Schramm","year":"2014","journal-title":"Mol.Immunol."},{"key":"10.1016\/j.clim.2020.108391_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01007","article-title":"The challenges and promise of complement therapeutics for ocular diseases","volume":"10","author":"Park","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2020.108391_bb0035","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/s41573-019-0031-6","article-title":"Clinical promise of next-generation complement therapeutics","volume":"18","author":"Mastellos","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.clim.2020.108391_bb0040","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1001\/jamaophthalmol.2018.1544","article-title":"Chroma and spectri study investigators, efficacy and safety of lampalizumab for geographic atrophy due to age-related macular degeneration: chroma and spectri phase 3 randomized clinical trials","volume":"136","author":"Holz","year":"2018","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.clim.2020.108391_bb0045","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/nrneph.2017.156","article-title":"The renaissance of complement therapeutics","volume":"14","author":"Ricklin","year":"2018","journal-title":"Nat.Rev.Nephrol."},{"key":"10.1016\/j.clim.2020.108391_bb0050","series-title":"A Novel Complement C5 Inhibitor, Met its Primary Endpoint and Reached Statistical Significance in a Phase 2b Randomized, Controlled Clinical Trial in Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration","author":"IVERIC bio\u2019\u2019s Zimura\u00ae","year":"2019"},{"key":"10.1016\/j.clim.2020.108391_bb0055","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.imbio.2015.06.012","article-title":"Therapeutic control of complement activation at the level of the central component C3","volume":"221","author":"Ricklin","year":"2015","journal-title":"Immunobiology."},{"key":"10.1016\/j.clim.2020.108391_bb0060","doi-asserted-by":"crossref","first-page":"7348","DOI":"10.1038\/s41598-018-25557-8","article-title":"Classical and alternative complement activation on photoreceptor outer segments drives monocyte-dependent retinal atrophy","volume":"8","author":"Katschke","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.clim.2020.108391_bb0065","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/eci.12419","article-title":"Compstatin: a C3-targeted complement inhibitor reaching its prime for bedside intervention","volume":"45","author":"Mastellos","year":"2015","journal-title":"Eur.J.Clin.Invest."},{"key":"10.1016\/j.clim.2020.108391_bb0070","article-title":"A multicenter, proof-of-concept study of intravitreal AL-78898A in patients with Geograhic Atrophy (GA) associated with Age-Related Macular Degeneration (AMD)","author":"Alcon Research","year":"2013","journal-title":"Clin. Identifier"},{"key":"10.1016\/j.clim.2020.108391_bb0075","author":"Apellis Pharmaceuticals"},{"key":"10.1016\/j.clim.2020.108391_bb0080","author":"Apellis Pharmaceuticals"},{"key":"10.1016\/j.clim.2020.108391_bb0085","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ophtha.2019.07.011","article-title":"Complement C3 inhibitor pegcetacoplan for geographic atrophy secondary to age-related macular degeneration","volume":"127","author":"Liao","year":"2020","journal-title":"Ophthalmology."},{"key":"10.1016\/j.clim.2020.108391_bb0090","doi-asserted-by":"crossref","first-page":"16229","DOI":"10.1074\/jbc.M110.204701","article-title":"Polyethylene glycol (PEG)-induced mouse model of choroidal neovascularization","volume":"286","author":"Lyzogubov","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2020.108391_bb0095","author":"Ophthotech Corporation"},{"key":"10.1016\/j.clim.2020.108391_bb0100","doi-asserted-by":"crossref","first-page":"6153","DOI":"10.1021\/acs.jmedchem.8b00560","article-title":"New analogs of the complement C3 inhibitor compstatin with increased solubility and improved pharmacokinetic profile","volume":"61","author":"Berger","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.clim.2020.108391_bb0105","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.imbio.2012.06.003","article-title":"New analogs of the clinical complement inhibitor compstatin with subnanomolar affinity and enhanced pharmacokinetic properties","volume":"218","author":"Qu","year":"2013","journal-title":"Immunobiology."},{"key":"10.1016\/j.clim.2020.108391_bb0110","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.clim.2018.09.004","article-title":"Safety profile after prolonged C3 inhibition","volume":"197","author":"Reis","year":"2018","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2020.108391_bb0115","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3389\/fimmu.2019.00406","article-title":"Complement-dependent mechanisms and interventions in periodontal disease","volume":"10","author":"Hajishengallis","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2020.108391_bb0120","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.clim.2018.11.010","article-title":"Taming hemodialysis-induced inflammation: are complement C3 inhibitors a viable option?","volume":"198","author":"Mastellos","year":"2019","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2020.108391_bb0125","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.clim.2016.08.017","article-title":"Compstatin Cp40 blocks hematin-mediated deposition of C3b fragments on erythrocytes: implications for treatment of malarial anemia","volume":"171","author":"Lindorfer","year":"2016","journal-title":"Clin.Immunol."},{"key":"10.1016\/j.clim.2020.108391_bb0130","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0022-1759(89)90248-2","article-title":"Preparation of monoclonal antibodies to C3b by immunization with C3b(i)-Sepharose","volume":"120","author":"Tosic","year":"1989","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.clim.2020.108391_bb0135","author":"Apellis Pharmaceuticals"},{"key":"10.1016\/j.clim.2020.108391_bb0140","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ophtha.2019.09.008","article-title":"C3 function and inhibition in geographic atrophy: interesting insights from a phase 2 study","volume":"127","author":"Wong","year":"2020","journal-title":"Ophthalmology."},{"key":"10.1016\/j.clim.2020.108391_bb0145","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jchromb.2016.12.004","article-title":"Method development and validation for the quantitation of the complement inhibitor Cp40 in human and cynomolgus monkey plasma by UPLC-ESI-MS","volume":"1041\u20131042","author":"Primikyri","year":"2017","journal-title":"J.Chromatogr.B Anal. Sci."},{"key":"10.1016\/j.clim.2020.108391_bb0150","doi-asserted-by":"crossref","first-page":"6628","DOI":"10.1167\/iovs.12-9587","article-title":"Activation of the alternative complement pathway in vitreous is controlled by genetics in age-related macular degeneration","volume":"53","author":"Loyet","year":"2012","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.clim.2020.108391_bb0155","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1182\/blood-2013-11-536573","article-title":"Peptide inhibitors of C3 activation as a novel strategy of complement inhibition for the treatment of paroxysmal nocturnal hemoglobinuria","volume":"123","author":"Risitano","year":"2014","journal-title":"Blood."},{"key":"10.1016\/j.clim.2020.108391_bb0160","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/biot.200900218","article-title":"PEGylation of therapeutic proteins","volume":"5","author":"Jevsevar","year":"2010","journal-title":"Biotechnol. J."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661620301698?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661620301698?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:02:46Z","timestamp":1761494566000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661620301698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":32,"alternative-id":["S1521661620301698"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2020.108391","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prolonged intraocular residence and retinal tissue distribution of a fourth-generation compstatin-based C3 inhibitor in non-human primates","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2020.108391","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108391"}}